ACORDA THERAPEUTICS INC's ticker is and the CUSIP is 00484MAA4. A total of 34 filers reported holding ACORDA THERAPEUTICS INC in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $6,139,000 | -35.0% | 7,500,000 | -30.2% | 0.19% | -50.1% |
| Q2 2016 | $9,439,000 | +5.7% | 10,750,000 | +7.5% | 0.38% | +1.3% |
| Q1 2016 | $8,928,000 | -22.6% | 10,000,000 | 0.0% | 0.38% | -37.1% |
| Q4 2015 | $11,533,000 | +26.1% | 10,000,000 | 0.0% | 0.60% | +9.1% |
| Q3 2015 | $9,143,000 | -9.6% | 10,000,000 | 0.0% | 0.55% | +25.2% |
| Q2 2015 | $10,119,000 | -1.1% | 10,000,000 | 0.0% | 0.44% | -21.1% |
| Q1 2015 | $10,227,000 | -11.2% | 10,000,000 | 0.0% | 0.56% | -9.0% |
| Q4 2014 | $11,511,000 | – | 10,000,000 | – | 0.61% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opti Capital Management, LP | 7,500 | $6,276,000 | 2.99% |
| PFM Health Sciences, LP | 90,886,000 | $75,652,000 | 2.01% |
| Jabre Capital Partners S.A. | 1,750,000 | $1,474,000 | 1.68% |
| Partner Investment Management, L.P. | 1,108,000 | $922,000 | 1.15% |
| Telemetry Investments, L.L.C. | 2,000,000 | $1,655,000 | 1.06% |
| Worth Venture Partners, LLC | 1,562,000 | $1,312,000 | 0.99% |
| DLD Asset Management, LP | 12,000,000 | $10,028,000 | 0.69% |
| Castle Creek Arbitrage, LLC | 2,310,000 | $1,937,000 | 0.67% |
| CANYON CAPITAL ADVISORS LLC | 28,775,000 | $23,830,000 | 0.56% |
| SYMPHONY ASSET MANAGEMENT LLC | 2,000,000 | $1,665,000 | 0.49% |